Pieter van Hagen,Maarten C.C.M. Hulshof,J. Jan B. van Lanschot,Ewout W. Steyerberg,Mark I. van Berge Henegouwen,Bas P. L. Wijnhoven,Dick J. Richel,Grard A. P. Nieuwenhuijzen,Geke A.P. Hospers,Johannes J. Bonenkamp,Miguel A. Cuesta,R.J.B. Blaisse,Olivier R. Busch,F.J.W. ten Kate,G.J. Creemers,C.J.A. Punt,John Theodorus Plukker,Henk M.W. Verheul,Ernst Jan Spillenaar Bilgen,Herman van Dekken
The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemoradiotherapy followed by surgery with surgery alone in this patient population.